The global antisense therapy market is affected by regulatory requirements specific to oligonucleotide medicines. Developers must evaluate pharmacokinetics, pharmacodynamics, safety, dosing, and potential immune responses, with assessments tailored to the chemistry and mechanism of each product.
The antisense therapy market was valued at US$ 6.17 billion in 2025 and is projected to reach US$...
Russian
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek